首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   14875篇
  免费   735篇
  国内免费   433篇
耳鼻咽喉   133篇
儿科学   498篇
妇产科学   149篇
基础医学   2695篇
口腔科学   243篇
临床医学   1032篇
内科学   1972篇
皮肤病学   238篇
神经病学   1706篇
特种医学   366篇
外科学   2001篇
综合类   1464篇
现状与发展   2篇
一般理论   1篇
预防医学   605篇
眼科学   181篇
药学   2026篇
  2篇
中国医学   495篇
肿瘤学   234篇
  2023年   137篇
  2022年   353篇
  2021年   483篇
  2020年   350篇
  2019年   316篇
  2018年   316篇
  2017年   336篇
  2016年   354篇
  2015年   351篇
  2014年   599篇
  2013年   851篇
  2012年   610篇
  2011年   676篇
  2010年   549篇
  2009年   651篇
  2008年   686篇
  2007年   595篇
  2006年   599篇
  2005年   549篇
  2004年   428篇
  2003年   477篇
  2002年   352篇
  2001年   338篇
  2000年   277篇
  1999年   296篇
  1998年   306篇
  1997年   288篇
  1996年   295篇
  1995年   277篇
  1994年   269篇
  1993年   237篇
  1992年   211篇
  1991年   230篇
  1990年   177篇
  1989年   176篇
  1988年   166篇
  1987年   187篇
  1986年   171篇
  1985年   239篇
  1984年   220篇
  1983年   142篇
  1982年   179篇
  1981年   148篇
  1980年   164篇
  1979年   103篇
  1978年   87篇
  1977年   67篇
  1976年   58篇
  1975年   21篇
  1974年   21篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
SUMMARY: Inhibition of mevalonate synthesis by several statins has been shown to suppress DNA synthesis in glomerular mesangial cells. In the present study, we investigated the effect of a new statin, cerivastatin, on fetal calf serum (FCS)-induced DNA synthesis of cultured rat mesangial cells. Cultured rat mesangial cells were stimulated by 10% FCS in the presence or absence of cerivastatin and mevalonate. 5-bromo-2-deoxyuridine (BrdU) incorporation was used to assess DNA synthesis. the present study showed that 10% FCS caused marked stimulation of DNA synthesis in the mesangial cells. Cerivastatin inhibited FCS-stimulated BrdU incorporation in a dose-dependent manner. IC50 was approximately 1 umol/L. Exogenous mevalonate, farnesyl pyrophosphate and geranylgeranyl pyrophosphate significantly prevented the inhibitory effect of cerivastatin on DNA replication. It appears that cerivastatin, by inhibiting the synthesis of mevalonate, may suppress DNA synthesis in the mesangial cells.  相似文献   
42.
重症肌无力术后延长拔管时间的临床价值   总被引:6,自引:0,他引:6  
目的 探讨重症肌无力 (MG)胸腺切除术后 ,延长气管拔管时间 ,减少气管切开的价值。方法 回顾分析 1978年至 2 0 0 2年 12月行MG胸腺切除 2 36例 ,按时间分A组 :1996年 12月以前手术者116例 ,对术后可能发生肌无力危象的高危因素病人施行预防性气管切开 ;B组 :1997年后手术 12 0例 ,对具发生危象高危因素者采用延长气管拔管时间 ,并对两组危象发生率及气管切开率进行比较。结果 全组发生危象 4 4例 (18 6 % ) ,气管切开 4 6例 (ARDS 1例除外 )占 19 5 %。其中A组发生危象 2 3例(19 8% ) ,气管切开 34例 (2 9 3% ) ;B组发生危象 2 1例 (17 5 % ) ,气管切开 12例 (10 % )。两组危象发生率无明显差异 ,但A组的气管切开率明显高于B组 (P <0 0 0 1)。结论 对MG胸腺切除术后具发生危象高危因素病人 ,采用延长气管插管时间及辅助通气 ,可显著减少气管切开率。  相似文献   
43.
Summary: Oral administration of carbamazepine (CBZ)(15, 10, or 5 mg/kg) to mice significantly decreased both humoral and cellular immune responses evaluated by enumeration of direct and indirect plaque-forming spleen cells (PFC) and delayed–type hypersensitivity reaction (DTH) against sheep red blood cells (SRBC) as compared with those observed in normal control animals. Moreover, spleen T cells obtained from CBZ–treated donor mice were capable of decreasing both PFC and DTH responses of normal spleen cells transferred into lethally irradiated recipient animals. The immunodepressor effect of CBZ was observed even though administration of CBZ induced augmentation of spleen cellularity.  相似文献   
44.
用心肌细胞跨膜电位记录,证实高浓度Ba~■(4mol/L)可诱发豚鼠心室肌自发电活性,这种自发电活性主要来自延迟后除极电位(DAD)及触发活动,且可被维拉帕米(异搏定)阻断,提示DAD的产生与钙离子内流有关。  相似文献   
45.
Single photon emission computerized tomography (SPECT) is now widely used as one of the tools in evaluating cerebral blood flow (CBF). The authors report the CBF changes in childhood hydrocephalus. Five pediatric cases studied by 123I-IM SPECT in children are presented. The authors counted radioactivities both in early and delayed images in each patient, and calculated the reabsorption ratio (RR). Two negative-RR cases and three positive-RR cases were found. All of the negative-RR patients had a poor prognosis, while all of the positive-RR patients had a favorable outcome.  相似文献   
46.
Summary: The present studies assessed the effects of manipulating extracellular sodium (Na) concentration and Na transport on cellular hypertrophy and hyperplasia in primary culture of rat proximal tubular cells. A concentration-dependent effect on thymidine incorporation and protein content was observed with cell culture media Na concentration of 130, 140 and 150 mmol/L. This effect was independent of osmolality (matched with mannitol) and no stimulatory effect occurred if choline was substituted for Na. Cells derived from sham-operated (Sx) animals exposed to a higher media concentration of Na (150 vs 140 mmol/L) had both stimulated thymidine incorporation to 186.8 ± 35.41% (P<0.05) and enhanced cell protein content to 134.7 ± 135% (P<0.05). This effect was more pronounced in cell cultures derived from unilaterally nephrectomized (Nx) animals, being 212.8 ± 31.5% (P<0.01) for thymidine incorporation (P<0.05 vs cells from sham-operated animals grown in high Na media) and 114.4 ± 3.2% (P<0.001) for protein content (P=0.11 vs sham-operated cells grown in similar conditions). the addition of 10?4 mmol/L ethylisopropyl amiloride hydrochloride (EIPA) to Nx cells in a normal or high Na concentration media resulted in a decrease in cellular protein content to 82.6 ± 6.8% (P<0.05) and 85.5 ± 0.2% (P<0.0001) compared to respective controls. 10?4 mol/L EIPA in media supplemented with insulin-like growth factor (IGF-1) blocked the proliferative response normally seen in response to this growth factor from 156.6 ± 13.7 to 27.5 ± 3.1% (P<0.0001) compared to control. However, the presence of EIPA did not abrogate the hypertrophic response elicited by IGF-1 (cell protein content 128.1 ± 13.1% of control with IGF-1 vs 124.9 ± 12.5 with IGF-1 and EIPA; P= n.s.). Addition of 10?4 mol/L EIPA to 10% serum derived from either Sx or Nx animals blocked the growth response to the sera, limiting the cellular protein content to 76.6 ± 5.5% (P<0.0001) and 89.7 ± 4.4% (P<0.0001) and thymidine incorporation to quiescent levels of 0.2 ± 0.1% (P<0.0001) and 0.4 ± 0.1% (P<0.0001) compared to respective controls. In summary, rat renal proximal tubular cell growth is influenced by Na concentrations in the cell culture environment and inhibited in the presence of EIPA. This supports a role for altered epithelial transport in the cellular growth response to a number of stimuli.  相似文献   
47.
采用间接ELISA检测23名肾移植受者血清巨细胞病毒(CMV)抗体,共检出18名(78%)活动性CMV感染,其中10名(44%)为原发性感染。结果证实CMV-IgE和-IgA具有较好的血清学诊断价值,优于CMV-IgM。  相似文献   
48.
Objective:To explore the effect of the Nephritis No.3(N-3)recipe on nitric oxide(NO),nitric oxide synthase(NOS)secreted by cultured mesangial cells(MC)and its gene expression of the in-ducible nitric oxide synthase(iNOS).Methods:The drug(nephritis No.3)-containing serum was preparedwith serum pharmacological technique,and then was applied to react on mesangial cells cultured In fetalcalf serum(FCS)and cells cultured in FCS plus lipopolysaccharide.To observe the secretion of NO andNOS and the gene expression of iNOS by means of RT-PCR.Results:Under the two kinds of culture con-ditions,the content of NO and NOS in the groups with drug-containing serum were higher than thosewithout drug-containing serum(P<0.05,P<0.01),and the expression of iNOS mRNA was up-regula-ted too.Conclusion:The N-3 could significantly promote the secretion of NO and NOS and the mRNA ex-pression of iNOS in rats.  相似文献   
49.
段金生  姚咏芳 《上海口腔医学》2004,13(2):146-146,149
复习46例延迟复位固定的颌骨骨折病例,对延迟复位固定的时间、原因、治疗和愈合情况等进行回顾分析:延迟时间最短2d,最长12d;延迟治疗的原因多种多样,所有病例均采用手术治疗。结果,延迟2~5d复位同定者6例,均一期愈合;延迟5-10d复位同定者31例,27例一期愈合;延迟10-12d复位固定者9例,均一期愈合。  相似文献   
50.
目的观察CO中毒致迟发性脑病(DNS)大鼠脑内CD4^+T淋巴细胞浸润以及神经胶质酸性蛋白(GFAP)的表达情况,探讨CO中毒致DNS的病理过程。方法25只SD雄性大鼠随机分为对照组、染毒后3、7、10、20d组,每组5只。采用HE和免疫组织化学染色方法,观察染毒后各时间点大鼠脑内病理形态学变化,及CD4^+T淋巴细胞浸润和GFAP的表达情况。结果HE染色结果显示:各染毒组在大脑皮层及海马均出现神经细胞不同程度的变性、坏死,染毒后7d组最重。免疫组织化学染色结果显示:对照组无CD4^+T淋巴细胞浸润,有少量GFAP表达;各染毒组不同脑区CD4^+T淋巴细胞、GFAP均有不同程度的浸润和表达。CD4^+T淋巴细胞染毒后3d开始浸润,7d达峰值,两者在数量上差异有统计学意义(P〈0.01)。各组染毒后GFAP均有大量表达,随染毒时间延长表达数量呈上升趋势。结论CD4^+T淋巴细胞可能参与了CO中毒致DNS的免疫病理过程,GFAP阳性细胞对CO中毒引发的DNS可能具有保护作用。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号